Patterns of perioperative prophylaxis for cataract surgery in Canada

Canadian Journal of Ophthalmology

Volumn 42, Issue 5, 2007, Pages 681-688

  Hammoudi, Dena S ^a,b   Abdolell, Mohamed ^c   Wong, David T ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Antibiotic prophylaxis; Canada; Cataract extraction; Endophthalmitis

Indexed keywords

ANTIBIOTIC AGENT; DICLOFENAC; NONSTEROID ANTIINFLAMMATORY AGENT; POVIDONE IODINE;

ARTICLE; CANADA; CATARACT EXTRACTION; CONTROLLED STUDY; ENDOPHTHALMITIS; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; PERIOPERATIVE PERIOD; VITREOUS BODY;

EID: 36348976829     PISSN: 00084182     EISSN: 17153360     Source Type: Journal    
DOI: 10.3129/I07-122     Document Type: Article

References (41)

1. Powe NR, Schein OD, Gieser SC, et al. Synthesis of the literature on visual acuity and complications following cataract extraction with intraocular lens implantation. Cataract Patient Outcome Research Team. Arch Ophthalmol 1994;112(2):239-52.
2. Ciulla TA, Starr MB, Masket S. Bacterial endophthalmitis prophylaxis for cataract surgery: an evidence-based update. Ophthalmobgy 2002;109(1):13-24.
3. Recchia FM, Busbee BG, Pearlman RB, Carvalho-Recchia CA, Ho AC. Changing trends in the microbiologic aspects of post-cataract endophthalmitis. Arch Ophthalmol 2005;123(3):341-6.
4. Masket S. Preventing, diagnosing, and treating endophthalmitis. J Cataract Refract Surg 1998;24(6):725-6.
5. Morlet N, Gatus B, Coroneo M. Patterns of peri-operative prophylaxis for cataract surgery: a survey of Australian ophthalmologists. Aust N Z J Ophthalmol 1998;26(1):5-12.
6. Elder M, Tarr K, Learning D. The New Zealand Cataract and Refractive Surgery Survey 1997/1998. Clin Experiment Ophthalmol 2000;28(2):89-95.
7. Elder M, Learning D. The New Zealand Cataract and Refractive Surgery Survey 2001. Clin Experiment Ophthalmol 2003;31(2):114-20.
8. Ang GS, Barras CW. Prophylaxis against infection in cataract surgery: a survey of routine practice. Eur J Ophthalmol 2006; 16(3):394-400.
9. Dinakaran S, Crome DA. Prophylactic measures prevalent in the United Kingdom. J Cataract Refract Surg 2002;28(3):387-8.
10. Schmitz S, Dick HB, Krummenauer F, Pfeiffer N. Endophthalmitis in cataract surgery: results of a German survey. Ophthalmology 1999;106(10):1869-77.
11. Hansen TE. Current trends in cataract surgery in Denmark - 1998 survey. Acta Ophthalmol Scand 1999;77(6):685-9.
12. Krootila K. Practice styles and preferences of Finnish cataract surgeons - 1998 survey. Acta Ophthalmol Scand 1999; 77(5):544-7.
13. R Development Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria; 2007. Available at: http://www.R-project.org. Accessed April 1, 2007.
14. Liesegang TJ. Use of antimicrobials to prevent postoperative infection in patients with cataracts. Curr Opin Ophthalmol 2001;12(1):68-74.
15. Speaker MG, Milch FA, Shah MK, et al. Role of external bacterial flora in the pathogenesis of acute postoperative endophthalmitis. Ophthalmology 1991;98(5):639-49; discussion 50.
16. Hanioglu-Kargi S, Basci N, Soysal H, et al. The penetration of ofloxacin into human aqueous humor given by various routes. Eur J Ophthalmol 1998;8(1):33-6.
17. Kobayakawa S, Tochikubo T, Tsuji A. Penetration of levofloxacin into human aqueous humor. Ophthalmic Res 2003;35(2):97-101.
18. Solomon R, Donnenfeld ED, Perry HD, et al. Penetration of topically applied gatifloxacin 0.3%, moxifloxacin 0.5%, and ciprofloxacin 0.3% into the aqueous humor. Ophthalmology 2005;112(3):466-9.
19. Kim DH, Stark WJ, O'Brien TP. Ocular penetration of moxifloxacin 0.5% and gatifloxacin 0.3% ophthalmic solutions into the aqueous humor following topical administration prior to routine cataract surgery. Curr Med Res Opin 2005;21(1):93-4.
20. Kowalski RP, Romanowski EG, Mah FS, Yates KA, Gordon YJ. Topical prophylaxis with moxifloxacin prevents endophthalmitis in a rabbit model. Am J Ophthalmol 2004;138(1):33-7.
21. Allen HF, Mangiaracine AB. Bacterial endophthalmitis after cataract extraction. A study of 22 infections in 20,000 operations. Arch Ophthalmol 1964;72:454-62.
22. Allen HF, Mangiaracine AB. Bacterial endophthalmitis after cataract extraction. II. Incidence in 36,000 consecutive operations with special reference to preoperative topical antibiotics. Arch Ophthalmol 1974;91(1):3-7.
23. Locatcher-Khorazo D, Gutierrez E. Eye infections following cataract extraction with special reference to the role of Staphylococcus aureus. Am J Ophthalmol 1956;41:981-7.
24. Callahan A. Effect of sulfonamides and antibiotics on panophthalmitis complicating cataract extraction. Arch Ophthalmol 1953;237:89-92.
25. Dunnington JH Locatcher-Khorazo D. Value of cultures before operation for cataract. Arch Ophthalmol 1945;34:215-9.
26. Jensen MK, Fiscella RG, Crandall AS, et al. A retrospective study of endophthalmitis rates comparing quinolone antibiotics. Am J Ophthalmol 2005;139(1):141-8.
27. Kunimoto DY, Sharma S, Garg P, Rao GN. In vitro susceptibility of bacterial keratitis pathogens to ciprofloxacin. Emerging resistance. Ophthalmology 1999;106(1):80-5.
28. Knauf HP, Silvany R, Southern PM, Risser RC, Wilson SE. Susceptibility of corneal and conjunctival pathogens to ciprofloxacin. Cornea 1996;15(1):66-71.
29. Montan PG, Wejde G, Koranyi G, Rylander M. Prophylactic intracameral cefuroxime. Efficacy in preventing endophthalmitis after cataract surgery. J Cataract Refract Surg 2002;28(6):977-81.
30. Axer-Siegel R, Stiebel-Kalish H, Rosenblatt I, Strassmann E, Yassur Y, Weinburger D. Cystoid macular edema after cataract surgery with intraocular vancomycin. Ophthalmology 1999;106(9):1660-4.
31. Lehmann OJ, Roberts CJ, Ikram K, Campbell MJ, McGill JI. Association between nonadministration of subconjunctival cefuroxime and postoperative endophthalmitis. J Cataract Refract Surg 1997;23(6):889-93.
32. Colleaux KM, Hamilton WK. Effect of prophylactic antibiotics and incision type on the incidence of endophthalmitis after cataract surgery. Can J Ophthalmol 2000;35(7):373-8.
33. Pande M. Postoperative conjunctival Chemosis in cataract surgery caused by subconjunctival gentamicin injection. Br J Ophthalmol 1991;75(11):660-2.
34. Chapman JM, Abdelatif OM, Cheeks L, Green K. Subconjunctival gentamicin induction of extraocular toxic muscle myopathy. Ophthalmic Res 1992;24(4):189-96.
35. Judson PH. Aminoglycoside macular toxicity after subconjunctival injection. Case report. Arch Ophthalmol 1989;107(9): 1282-3.
36. Campochiaro PA, Conway BR Aminoglycoside toxicity - a survey of retinal specialists. Implications for ocular use. Arch Ophthalmol 1991;109(7):946-50.
37. Sanders R, MacEwen CJ, Haining WM. A comparison of prophylactic, topical and subconjunctival treatment in cataract surgery. Eye 1992;6(Pt 1):105-10.
38. el Baba FZ, Trousdale MD, Gauderman WJ, Wagner DG, Liggett PE. Intravitreal penetration of oral ciprofloxacin in humans. Ophthalmology 1992;99(4):483-6.
39. Starr MB. Prophylactic antibiotics for ophdialmic surgery. Surv Ophthalmol 1983;27(6):353-73.
40. Learning DV. Practice styles and preferences of ASCRS members - 2003 survey. J Cataract Refract Surg 2004;30(4):892-900.
41. Learning DV. Practice styles and preferences of ASCRS members - 2000 survey. American Society of Cataract and Refractive Surgery. J Cataract Refract Surg 2001;27(6):948-55.